Month: June 2021

NEW YORK, June 15, 2021 (GLOBE NEWSWIRE) — Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced that Jerry Durso, President and Chief Executive Officer of Intercept, will present at the Raymond James 2021 Human Health Innovation Conference on Tuesday, June 22, 2021 at 1:20 p.m. ET. A live webcast of the event will be available on the investor page of Intercept’s website at http://ir.interceptpharma.com. An audio archive of the webcast will also be available on Intercept’s website for approximately two weeks. About InterceptIntercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases,...

Agile experience management company formerly operating as SVMK Inc. will celebrate its relaunch by ringing The Closing Bell® today SAN MATEO, Calif., June 15, 2021 (GLOBE NEWSWIRE) — Momentive (NASDAQ: MNTV), an agile experience management company formerly known as SurveyMonkey, announced that the company will begin trading under the new ticker symbol MNTV, and ring The Closing Bell® virtually today to celebrate the company’s relaunch first announced on June 9, 2021. “We are very proud to make our NASDAQ debut as Momentive,” said CEO Zander Lurie. “Our new brand symbolizes momentum and adaptability, and reflects the breadth of our agile experience management and insights solutions that bring together the best of humanity and technology. Today, more than 8,800 enterprise customers like IBM, KLM, LG Electronics, and PUMA rely on...

CALGARY, Alberta, June 15, 2021 (GLOBE NEWSWIRE) — Badger Infrastructure Solutions Ltd. (“Badger”) is pleased to announce its June 2021 cash dividend and upcoming events. June 2021 Cash DividendBadger today announced that the directors of Badger declared a cash dividend for the month of June 2021 of $0.0525 per share, which equates to $0.63 per share on an annualized basis. Payment will be made on or about July 15, 2021, to shareholders of record on June 30, 2021. Badger expects that the dividend will be an “eligible dividend” for Canadian income tax purposes and thus qualify for the enhanced gross-up and tax credit regime for certain shareholders. 2021 Second Quarter Results and Conference Call Badger expects to release its 2021 second quarter results on Thursday, August 5, 2021, after the close of market trading. A conference...

RIDGEFIELD, Conn., June 15, 2021 (GLOBE NEWSWIRE) — The Chefs’ Warehouse, Inc. (NASDAQ: CHEF) (“Chefs’ Warehouse” or the “Company”), a premier distributor of specialty food products in the United States and Canada, today announced that the Company will virtually present at the Jefferies Consumer Conference on Tuesday, June 22, 2021. The presentation will begin at 9:10 a.m. ET. Investors and interested parties may listen to a webcast of the presentation by visiting the Company’s investor relations website at http://investors.chefswarehouse.com/. About The Chefs’ Warehouse The Chefs’ Warehouse, Inc. (http://www.chefswarehouse.com) is a premier distributor and manufacturer of specialty food products in the United States and Canada focused on serving the specific needs of chefs who own and/or operate some of the nation’s leading...

TORONTO, June 15, 2021 (GLOBE NEWSWIRE) — Flow Capital Corp. (TSXV: FW) (“Flow Capital”) today announces that it has provided an investment to Performio, an Irvine-based SaaS software Incentive Compensation Management solution. Founded in Melbourne, Australia in 2006, Performio was designed to be flexible and easy to use for mid-market and enterprise companies looking to automate their sales compensation programs. Since its inception, Performio has processed over $2 billion in commissions and has saved its customers over 1 million administrative hours. With Flow Capital’s investment, Performio is aiming to accelerate its growth within the US. “Performio saw over 100% revenue growth in North America in 2020. Flow Capital’s investment will help them invest in sales and marketing more aggressively to further accelerate that sales...

– Collaboration leverages expertise and capabilities of both companies towards developing life-changing treatments for severe neurological diseases – ZUG, Switzerland and CAMBRIDGE, Mass. and THOUSAND OAKS, Calif., June 15, 2021 (GLOBE NEWSWIRE) — CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on developing transformative gene-based medicines for serious diseases, and Capsida Biotherapeutics Inc., a biotechnology company dedicated to developing breakthrough gene therapies using fully integrated adeno-associated virus (AAV) engineering, cargo development and manufacturing, today announced a strategic partnership to research, develop, manufacture and commercialize in vivo gene editing therapies delivered with engineered AAV vectors for the treatment of familial amyotrophic lateral sclerosis (ALS)...

Phase 2 trial will evaluate the efficacy of once-weekly apraglutide in increasing intestinal energy absorption in CIC patients with SBS-IFCIC patients represent over half of the total SBS-IF populationInitial readout of 4-week intestinal energy absorption data expected in 1H22 BASEL, Switzerland, June 15, 2021 (GLOBE NEWSWIRE) — VectivBio Holding AG, (“Vectiv” or “VectivBio”) (Nasdaq: VECT), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of innovative treatments for severe rare conditions for which there is a significant unmet medical need, today announced it has dosed the first patient in its Phase 2 STARS Nutrition metabolic balance study evaluating apraglutide in colon-in-continuity (CIC) patients with short bowel syndrome with intestinal failure (SBS-IF). CIC patients...

68 shareholders were registered as attending at the Annual General Meeting, who owned 497,278,196 votes/shares (the amount of represented share capital 233,720,725 EUR), forming 74.23% of AS Tallink Grupp share capital. Resolutions adopted at the meeting: 1. To approve the Annual Report of 2020 of AS Tallink Grupp presented by the Management Board. In favour of the resolution voted 100% of the votes represented at the meeting (497,277,169 votes).   2. To approve the proposal presented by the management board of AS Tallink Grupp:1) To approve the net loss of the financial year of 2020 in the amount of 108,308,000 euros and to cover the net loss with the retained earnings;2) No dividend distribution to the shareholders. In favour of the resolution voted 100% of the votes represented at the meeting (497,271,167 votes).   3. To amend the second...